From tolerance to autoimmunity: Is there a risk in early life vaccination?

被引:29
作者
Goriely, S. [1 ]
Goldman, M. [1 ]
机构
[1] Univ Libre Bruxelles, Inst Med Immunol, B-6041 Charleroi, Belgium
关键词
vaccine; autoimmunity; Toll-like receptor; T helper cell;
D O I
10.1016/j.jcpa.2007.04.013
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The potential for vaccines to act as triggers of autoimmune reactions has received much recent attention. Such an association is very poorly defined mechanistically, but may potentially involve epitope mimicry between vaccinal and self antigen, or the immuno-stimulatory effects of vaccine adjuvant. If such reactions occur, they are more likely to involve adults than infants in early life, as a reflection of the immunological immaturity of the newborn. There has been a recent focus in immunology on the link between innate and adaptive immunity provided by a dendritic cells and the range of Toll-like receptors (TLRs) that are the point of first contact of these cells with microbial antigen. These interactions appear to determine the nature of the subsequent adaptive immune response and whether it may be mediated by Th1, Th2,Thl7 or Tregulatory populations. TLR interactions may also be significant in the induction of vaccinal immunity and agonists of these receptors are being developed as potential vaccine adjuvants. There are differences in cytokine production of adult and newborn dendritic cells, and these differences must be considered in the application of such novel adjuvants to products intended for either age group. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:S57 / S61
页数:5
相关论文
共 11 条
[1]  
AKOSY E, 2007, BLOOD, V109, P2887
[2]   Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells [J].
Batten, Marcel ;
Li, Ji ;
Yi, Sothy ;
Kljavin, Noelyn M. ;
Danilenko, Dimitry M. ;
Lucas, Sophie ;
Lee, James ;
de Sauvage, Frederic J. ;
Ghilardi, Nico .
NATURE IMMUNOLOGY, 2006, 7 (09) :929-936
[3]   Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice [J].
Berland, Robert ;
Fernandez, Luis ;
Kari, Elina ;
Han, Jin-Hwan ;
Lomakin, Ina ;
Akira, Shizuo ;
Wortis, Henry H. ;
Kearney, John F. ;
Ucci, Angelo A. ;
Imanishi-Kari, Thereza .
IMMUNITY, 2006, 25 (03) :429-440
[4]   Inferences, questions and possibilities in toll-like receptor signalling [J].
Beutler, B .
NATURE, 2004, 430 (6996) :257-263
[5]   Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus [J].
Christensen, Sean R. ;
Shupe, Jonathan ;
Nickerson, Kevin ;
Kashgarian, Michael ;
Flavell, Richard A. ;
Shlomchik, Mark J. .
IMMUNITY, 2006, 25 (03) :417-428
[6]   All in the family:: IL-27 suppression of TH-17 cells [J].
Colgan, John ;
Rothman, Paul .
NATURE IMMUNOLOGY, 2006, 7 (09) :899-901
[7]   Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain [J].
Cua, DJ ;
Sherlock, J ;
Chen, Y ;
Murphy, CA ;
Joyce, B ;
Seymour, B ;
Lucian, L ;
To, W ;
Kwan, S ;
Churakova, T ;
Zurawski, S ;
Wiekowski, M ;
Lira, SA ;
Gorman, D ;
Kastelein, RA ;
Sedgwick, JD .
NATURE, 2003, 421 (6924) :744-748
[8]   Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns [J].
De Wit, D ;
Olislagers, V ;
Goriely, S ;
Vermeulen, F ;
Wagner, H ;
Goldman, M ;
Willems, F .
BLOOD, 2004, 103 (03) :1030-1032
[9]   Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders [J].
Goldman, M. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 147 (02) :208-216
[10]   Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation [J].
Goriely, S ;
Molle, C ;
Nguyen, M ;
Albarani, V ;
Haddou, NO ;
Lin, RT ;
De Wit, D ;
Flamand, V ;
Willems, F ;
Goldman, M .
BLOOD, 2006, 107 (03) :1078-1084